n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Hodgkin-Disease* in 1 studies
1 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Hodgkin-Disease
| Article | Year |
|---|---|
Incidental Detection of a Hodgkin Lymphoma on 18F-Choline PET/CT and Comparison With 18F-FDG in a Patient With Prostate Cancer.
Combined PET/CT scanning with (18)F-FDG is in current use in Hodgkin lymphoma. New tracers have been developed, such as (18)F-choline in prostate cancer. Its use is under investigation in other solid tumors (eg, brain, liver, lung). We report a case of Hodgkin lymphoma incidentally detected on (18)F-choline PET/CT in a prostate cancer patient and show a comparison with (18)F-FDG PET/CT. (18)F-choline PET/CT detected more lymph node lesions than the (18)F-FDG PET/CT for this patient. Comparative studies of the 2 tracers might help fine-tune treatments and, in particular, delineate target zones in radiation therapy. Topics: Aged; Choline; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Incidental Findings; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |